DECA News and Press, Denali Capital Acquisition Corp. From 12/29/23

Denali Capital Acquisition Corp. Announces Postponement of Extraordinary General Meeting From Thursday, January 4, 2024 to Tuesday, January 9, 2024 PR Newswire NEW YORK , Dec. 29, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (Nasdaq: DECA) (the "Com...

2023-12-29 08:21:40 ET Microbot Medical ( MBOT ) -27% after announces exercise of outstanding preferred investment options for $2.73 million. Ucommune International ( UK ) -21% . SenesTech ( SNES ) -20% . Cingulate ( CING ) -20% . Bone B...

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination PR Newswire NEW YORK , Nov. 10, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that an aggregate of $50,...

Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination PR Newswire NEW YORK , Oct. 11, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that the...

Denali Capital Acquisition Corp. Announces Intention to Extend Deadline to Complete an Initial Business Combination PR Newswire NEW YORK , July 7, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" or the "Company") announced toda...

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete an Initial Business Combination PR Newswire NEW YORK , April 6, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" or the "Company") announced today tha...

Longevity Biomedical is going public on Nasdaq via a business combination with SPAC Denali Capital Acquisition ( NASDAQ: DECA ). The combined company will operate as Longevity Biomedical and is expected to list on Nasdaq under the symbol LBIO. The transaction repres...